Unlock Advanced Pharmaceutical Synthesis with 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline
Discover the critical role of CAS 183322-18-1 in developing next-generation cancer therapies. Reliable supply from leading Chinese manufacturers and suppliers ensures your research and production needs are met.
Get a Quote & SampleProduct Core Value
4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline
As a trusted supplier in China, we provide high-purity 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline, CAS 183322-18-1. This essential fine chemical intermediate is crucial for the synthesis of advanced pharmaceutical compounds, particularly in the field of oncology. Its unique chemical structure makes it a key component in the development of targeted therapies.
- Leverage our expertise as a reliable manufacturer in China for this vital pharmaceutical intermediate, ensuring consistent quality and supply.
- Explore the critical role of this compound in Erlotinib intermediate synthesis, a vital step in producing effective cancer treatments.
- Benefit from the high purity and precise specifications of our high purity fine chemical supply for your demanding research and development projects.
- Understand its function as an Aurora 2 kinase inhibitor and PDGF inhibitor for cancer, highlighting its therapeutic potential.
Advantages of Using Our Product
Exceptional Purity and Quality
We ensure rigorous quality control, delivering a product that meets stringent industry standards, essential for reliable pharmaceutical intermediate synthesis.
Critical for Targeted Therapies
As an indispensable component in the development of drugs like Erlotinib, this compound is key for advancing cancer treatment research, making it a cornerstone of API synthesis.
Reliable Supply Chain
Our robust supply chain as a leading Chinese manufacturer guarantees consistent availability, supporting uninterrupted research and production schedules for high purity fine chemical supply.
Key Applications
Pharmaceutical Synthesis
Essential for the complex pathways involved in API synthesis, enabling the creation of life-saving medications.
Cancer Research
A vital tool for researchers investigating new anti-cancer agents and mechanisms, including its role as an Aurora 2 kinase inhibitor.
Erlotinib Intermediate
Serves as a critical building block in the multi-step synthesis of Erlotinib, a significant cancer treatment medication.
Kinase Inhibitor Development
Supports the ongoing development of novel kinase inhibitors, vital for treating various diseases and conditions, as a key component in Erloitnib intermediate synthesis.